We are live on ! Find out more
CF

Corebridge Financial Portfolio holdings

AUM $4.25M
1-Year Est. Return 33.15%
This Fund
S&P 500
This Quarter Est. Return
-3.26%
1 Year Est. Return
-33.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$17.4B
AUM Growth
-$1.11B
Cap. Flow
-$117M
Cap. Flow %
-0.67%
Top 10 Hldgs %
25.42%
Holding
3,045
New
14
Increased
313
Reduced
2,663
Closed
30

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$39.3M
2
NVDA icon
NVIDIA
NVDA
+$38.8M
3
AAPL icon
Apple
AAPL
+$36.4M
4
WSM icon
Williams-Sonoma
WSM
+$21.8M
5
EXE
Expand Energy Corp
EXE
+$19.7M

Sector Composition

Rank Sector Weight
1 Technology 26.79%
2 Financials 13.87%
3 Consumer Discretionary 10.73%
4 Healthcare 10.45%
5 Industrials 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EDIT icon
2751
Editas Medicine
EDIT
$415M
$47.1K ﹤0.01%
40,602
-601
-1% -$884
FCEL icon
2752
FuelCell Energy
FCEL
$1.27B
$46.2K ﹤0.01%
10,057
+808
+9% +$6.03K
AEYE icon
2753
AudioEye
AEYE
$99.7M
$45.9K ﹤0.01%
4,136
+592
+17% +$8.94K
TAYD icon
2754
Taylor Devices
TAYD
$193M
$45.8K ﹤0.01%
1,419
-22
-2% -$723
VKTX icon
2755
Viking Therapeutics
VKTX
$3.73B
$45.6K ﹤0.01%
1,887
-73
-4% -$2.31K
FHTX icon
2756
Foghorn Therapeutics
FHTX
$262M
$45.2K ﹤0.01%
12,373
-184
-1% -$839
ACHV icon
2757
Achieve Life Sciences
ACHV
$726M
$45K ﹤0.01%
16,872
-251
-1% -$781
KOD icon
2758
Kodiak Sciences
KOD
$2.07B
$44.8K ﹤0.01%
15,984
-237
-1% -$1.29K
ADVM
2759
DELISTED
Adverum Biotechnologies
ADVM
$44.5K ﹤0.01%
10,192
-151
-1% -$681
ZNTL icon
2760
Zentalis Pharmaceuticals
ZNTL
$332M
$44.5K ﹤0.01%
27,996
-415
-1% -$895
CHRS icon
2761
Coherus Oncology
CHRS
$205M
$44.4K ﹤0.01%
55,061
-254
-0.5% -$292
UP icon
2762
Wheels Up
UP
$134M
$44.4K ﹤0.01%
2,197
-33
-1% -$909
LRMR icon
2763
Larimar Therapeutics
LRMR
$407M
$44.3K ﹤0.01%
20,609
-306
-1% -$967
VSTS icon
2764
Vestis
VSTS
$1.71B
$44.2K ﹤0.01%
4,468
-479
-10% -$6.36K
BTMD icon
2765
Biote Corp
BTMD
$38.1M
$43.9K ﹤0.01%
13,189
-194
-1% -$925
S icon
2766
SentinelOne
S
$6.87B
$43.7K ﹤0.01%
2,406
-49
-2% -$1.06K
BLNK icon
2767
Blink Charging
BLNK
$78.9M
$43.3K ﹤0.01%
47,132
-699
-1% -$809
SLDB icon
2768
Solid Biosciences
SLDB
$933M
$43.1K ﹤0.01%
11,643
+294
+3% +$1.26K
GEOS icon
2769
Geospace Technologies
GEOS
$66M
$43K ﹤0.01%
5,965
-89
-1% -$764
CERT icon
2770
Certara
CERT
$1.15B
$43K ﹤0.01%
4,343
-352
-7% -$4.28K
QIPT
2771
DELISTED
Quipt Home Medical
QIPT
$42.7K ﹤0.01%
18,327
-2,240
-11% -$6.14K
LYEL icon
2772
Lyell Immunopharma
LYEL
$293M
$42.4K ﹤0.01%
3,936
-59
-1% -$723
SNDR icon
2773
Schneider National
SNDR
$5.99B
$41.8K ﹤0.01%
1,829
-150
-8% -$4.06K
SGHT icon
2774
Sight Sciences
SGHT
$448M
$41.8K ﹤0.01%
17,405
-258
-1% -$727
NMRA icon
2775
Neumora Therapeutics
NMRA
$195M
$41.8K ﹤0.01%
41,753
-66
-0.2% -$113

Similar funds

Corebridge Financial's Q1 2025 Portfolio in Review

As of Q1 2025, Corebridge Financial held 3,045 positions worth $17.4B, down 6% from $18.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 1.4%. Corebridge Financial opened 14 new positions and exited 30, leaving the 3,045-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 30% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Corebridge Financial's largest Q1 2025 buy was State Street Blackstone Senior Loan ETF: 9,585,037 shares worth $394M.
  • Corebridge Financial added most to State Street SPDR Portfolio S&P 500 Growth ETF in Q1 2025, an estimated $19.5M increase.
  • Corebridge Financial's biggest Q1 2025 reduction was Microsoft, cutting an estimated $39.3M.
  • Corebridge Financial fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $10.6M.
  • Corebridge Financial's ten largest holdings make up 25% of its $17.4B portfolio in Q1 2025.
  • Corebridge Financial opened 14 new positions and closed 30 in Q1 2025.
  • Corebridge Financial's portfolio value fell 6% quarter-over-quarter to $17.4B.

Based on Corebridge Financial's 13F filing for Q1 2025, filed 14 May 2025.